CMT Research Foundation Partners to Study Inosine as CMT1X Therapy

CMT Research Foundation Partners to Study Inosine as CMT1X Therapy

298903

CMT Research Foundation Partners to Study Inosine as CMT1X Therapy

The CMT Research Foundation is teaming up with the University of Illinois Chicago (UIC) to investigate a potential treatment for X-linked Charcot-Marie-Tooth type 1 disease (CMTX1), the second most common type of CMT. Together, they aim to test whether inosine, an anti-inflammatory molecule, might act in ways that would ease CMT1X symptoms or change the course of the disease. Leading the project will be Charles Abrams, MD, PhD, a professor of neurology and rehabilitation at UIC.…

You must be logged in to read/download the full post.